Top member reports
Company Report
Last edited 3 years ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#288
Performance (39m)
-3.5% pa
Followed by
3
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#Bull Case
stale
Added 3 years ago

Early results but paxalisib shows some promise to improve survival in glioblastoma over current standard of care. KZA has patients enrolling in the industry standard gbm trial. Despite the volatility over the last year, i believe management when they say newsflow over the next two years will be good